Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Detection and Epidemiology of NAION in a Commercially Insured Population in the United States.

NCT01260324 is registered in ClinicalTrials.gov with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor.

NCT NCT01260324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01260324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Detection and Epidemiology of NAION in a Commercially Insured Population in the United States.
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
March 31, 2010
Enrollment
21,283 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anterior ischemic optic neuropathy, ischemic optic neuropathy